Amgen

About Amgen

Amgen is a leading biotechnology company dedicated to discovering, developing, and delivering innovative human therapeutics. Founded in 1980, the company has a rich history of scientific excellence and a commitment to improving patient outcomes through advanced biopharmaceuticals.

With a focus on areas such as oncology, cardiovascular disease, and bone health, Amgen leverages cutting-edge technology and research to create therapies that address significant unmet medical needs. The company’s robust pipeline includes a variety of biologic medicines that are designed to target specific diseases at their source.

Amgen operates globally, with a strong presence in the UK, where it collaborates with healthcare professionals, researchers, and patients to enhance the understanding and treatment of complex diseases. The company is committed to sustainability and ethical practices, ensuring that its operations contribute positively to society and the environment.

In addition to its innovative products, Amgen invests heavily in research and development, fostering a culture of scientific inquiry and collaboration. The company’s state-of-the-art facilities are equipped with the latest technologies, enabling scientists to push the boundaries of what is possible in biotechnology.

Amgen also prioritises patient access to its therapies, working closely with healthcare systems to ensure that patients can benefit from its groundbreaking treatments. Through partnerships and community engagement, Amgen strives to make a meaningful impact on global health.

As a leader in the biotechnology sector, Amgen is not only focused on financial success but also on making a difference in the lives of patients around the world. The company’s vision is to be the world’s leading biotechnology company, transforming the practice of medicine through innovation and compassion.